Receptos Inc (RCPT) financial statements (2022 and earlier)

Company profile

Business Address 3033 SCIENCE PARK ROAD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:671,90069,500
Cash and cash equivalents458,27823,805
Short-term investments 45,685
Other undisclosed cash, cash equivalents, and short-term investments213,62210
Prepaid expense1,727 
Prepaid expense and other current assets914
Other undisclosed current assets1,905(10)
Total current assets:675,53270,404
Noncurrent Assets
Property, plant and equipment966269
Other noncurrent assets1,509 
Prepaid expense and other noncurrent assets555
Total noncurrent assets:2,475824
TOTAL ASSETS:678,00771,228
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities28,52014,706
Accounts payable7,9095,096
Accrued liabilities16,1617,612
Employee-related liabilities4,4501,998
Debt 735
Deferred revenue and credits 700
Total current liabilities:28,52016,141
Noncurrent Liabilities
Long-term debt and lease obligation 4,180
Long-term debt, excluding current maturities 4,180
Liabilities, other than long-term debt 112
Deferred revenue and credits 112
Total noncurrent liabilities: 4,292
Total liabilities:28,52020,433
Stockholders' equity
Stockholders' equity attributable to parent649,48750,795
Common stock3118
Additional paid in capital860,384146,680
Accumulated other comprehensive income (loss)(49)6
Accumulated deficit(210,879)(95,909)
Total stockholders' equity:649,48750,795
TOTAL LIABILITIES AND EQUITY:678,00771,228

Income statement (P&L) ($ in thousands)

12/31/2014
12/31/2013
Revenues
(Revenue, Net)
5,9004,641
Gross profit:5,9004,641
Operating expenses(117,470)(52,534)
Operating loss:(111,570)(47,893)
Nonoperating income (expense)(2,491)16
Investment income, nonoperating42827
Foreign currency transaction loss, before tax(2,949) 
Other nonoperating income (expense)30(11)
Interest and debt expense(909)(443)
Net loss attributable to parent:(114,970)(48,320)
Other undisclosed net loss available to common stockholders, basic (2,056)
Net loss available to common stockholders, diluted:(114,970)(50,376)

Comprehensive Income ($ in thousands)

12/31/2014
12/31/2013
Net loss:(114,970)(48,320)
Comprehensive loss:(114,970)(48,320)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(55)6
Comprehensive loss, net of tax, attributable to parent:(115,025)(48,314)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: